I am not sure that big pharma doesnt make money off malaria. Maybe not as much money, but they will make profit off the manufacture of the products. Novartis justify investment in Artemether manufacture now. Any additional use, and in-field use would increase the uptake a lot, would produce better economies or scale and therefore increase any limited margins that may be there now.
- Forums
- ASX - By Stock
- ALA
- Artimist AGM
Artimist AGM, page-19
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALA (ASX) to my watchlist
|
|||||
Last
15.3¢ |
Change
-0.003(1.61%) |
Mkt cap ! $160.3M |
Open | High | Low | Value | Volume |
15.5¢ | 15.5¢ | 15.0¢ | $82.79K | 539.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 18124 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.5¢ | 108897 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18124 | 0.150 |
12 | 1004094 | 0.145 |
7 | 562682 | 0.140 |
8 | 297411 | 0.135 |
10 | 612354 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.155 | 108897 | 1 |
0.160 | 1719317 | 10 |
0.165 | 322812 | 1 |
0.170 | 327224 | 4 |
0.175 | 725336 | 5 |
Last trade - 15.46pm 12/07/2024 (20 minute delay) ? |
Featured News
ALA (ASX) Chart |